Global Lung Cancer Market Size, Trends & Analysis - Forecasts to 2028 By Surgical Devices (Surgical Hand Instruments, Monitoring & Visualization Systems, and Endoscopic Equipment), By Surgical Procedures (Thoracotomy, and Minimally Invasive Devices), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
The global lung cancer market is expected to grow at a CAGR of 6.5% from 2023 to 2028.
Lung cancer develops when abnormal cells in the lungs grow uncontrollably, forming tumours that can interfere with normal lung function and if left untreated, can spread to other parts of the body through the bloodstream or lymphatic system. The most significant risk factor for lung cancer is tobacco smoking including cigarette, cigar, and pipe smoking. However, lung cancer can also occur in non-smokers due to factors such as exposure to second-hand smoke, air pollution, asbestos, radon gas, and genetic predisposition. Early symptoms of lung cancer may include persistent cough, chest pain, and shortness of breath, hoarseness, and unexplained weight loss. Treatment for lung cancer depends on the type, stage, and extent of the disease. It may include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, or a combination of these approaches. Early detection and timely treatment are crucial for better outcomes and survival rates in lung cancer patients.
The global lung cancer market is driven by several key factors that influence its growth and development. One of the primary drivers is the increasing prevalence of lung cancer worldwide, which is attributed to factors such as smoking, exposure to carcinogens, and air pollution. The aging population is also contributing to the rising incidence of lung cancer, as the disease is more commonly diagnosed among older individuals.
Advancements in medical research and technology have led to early detection and improved diagnostic methods, enabling timely and accurate diagnosis, which further increases demand for lung cancer treatments. Additionally, innovative therapies and targeted treatments have emerged, offering more personalized and effective options for lung cancer patients, which further fuels the market growth. Moreover, government initiatives and investments in healthcare infrastructure, as well as increasing healthcare expenditure are facilitating better access to lung cancer treatments and promoting awareness about early screening programs.
Furthermore, a shift towards a healthier lifestyle and increased awareness about harmful effects of smoking and environmental pollutants are motivating individuals to take preventive measures, leading to a potential reduction in lung cancer cases. Overall, the global lung cancer market is driven by factors such as increasing prevalence of lung cancer, advancements in medical research and technology, innovative treatment options, government initiatives, and growing awareness about lung cancer prevention and early detection. These drivers are shaping the lung cancer market and efforts to improve patient outcomes and survival rates remain at the forefront of research and development in the field.
The market segmentation based on surgical devices category comprises three main categories: surgical hand instruments, monitoring and visualization systems, and endoscopic equipment. Among these segments, surgical hand instruments is anticipated to be the largest segment in the market. These instruments are essential tools used in a wide range of cancer surgical procedures, making them highly sought-after and widely utilized across various medical settings, contributing to their prominent position in the market.
On the basis of surgical procedures, the market is segmented into two categories such as thoracotomy and minimally invasive techniques. Thoracotomy involves a surgical incision into the chest to access the organs, while minimally invasive techniques use smaller incisions and advanced technology to perform surgeries with reduced trauma and faster recovery. Among these segments, minimally invasive techniques segment is expected to be have the largest share in the market. This is mainly due to the advantages of reduced patient discomfort, shorter hospital stays, and quicker post-operative recovery.
North America is analysed to be the largest market in the global lung cancer market during the forecast period. This is attributed to several factors including higher prevalence of lung cancer in the region, a well-established healthcare infrastructure, easy access to advanced medical technologies and surgical procedures, and increasing awareness about lung cancer screening and treatment options. Additionally, ongoing research and development activities and government initiatives further support the dominance of the North American region in the global lung cancer market.
Asia Pacific is projected to be the fastest-growing region in the global lung cancer market. This growth can be attributed to several factors such as rising prevalence of lung cancer in the region, a large and aging population, increasing healthcare expenditure, and advancements in medical infrastructure and technology. Additionally, growing awareness about lung cancer, early detection programs, and increasing adoption of innovative surgical techniques contribute to the rapid expansion of the lung cancer market in the Asia Pacific region.
Key players operating in the market include Olympus Corporation, Teleflex Incorporated, Ackermann Instrumente GmbH, Medtronic Plc., Siemens Healthcare, Richard Wolf GmbH, Phoenix Surgical Holdings Limited, FusionKraft, KLS Martin Group, and Sontec Instruments Inc., among others.
Please note: This is not an exhaustive list of companies profiled in the report.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
2.4 Data Metrics
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
4 GLOBAL LUNG CANCER MARKET, BY SURGICAL DEVICES
4.2 Lung Cancer Market: Application Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4.1 Surgical Hand Instruments Market Estimates and Forecast, 2020-2028 (USD Billion)
4.5 Monitoring & Visualization Systems
4.5.1 Monitoring & Visualization Systems Market Estimates and Forecast, 2020-2028 (USD Billion)
4.6.1 Endoscopic Equipment Market Estimates and Forecast, 2020-2028 (USD Billion)
5 GLOBAL LUNG CANCER MARKET, BY SURGICAL PROCEDURES
5.2 Lung Cancer Market: Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4.1 Thoracotomy Market Estimates and Forecast, 2020-2028 (USD Billion)
5.5 Minimally Invasive Devices
5.5.1 Minimally Invasive Devices Market Estimates and Forecast, 2020-2028 (USD Billion)
6 GLOBAL LUNG CANCER MARKET, BY REGION
6.2 North America Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.2.3.1 U.S. Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.2.3.1.2 By Surgical Procedures
6.2.3.2 Canada Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.2.3.2.2 By Surgical Procedures
6.2.3.3 Mexico Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.2.3.3.2 By Surgical Procedures
6.3 Europe Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.1 Germany Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.1.2 By Surgical Procedures
6.3.3.2 U.K. Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.2.2 By Surgical Procedures
6.3.3.3 France Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.3.2 By Surgical Procedures
6.3.3.4 Italy Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.4.2 By Surgical Procedures
6.3.3.5 Spain Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.5.2 By Surgical Procedures
6.3.3.6 Netherlands Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.6.2 By Surgical Procedures
6.3.3.7 Rest of Europe Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.3.3.6.2 By Surgical Procedures
6.4 Asia Pacific Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.1 China Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.1.2 By Surgical Procedures
6.4.3.2 Japan Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.2.2 By Surgical Procedures
6.4.3.3 India Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.3.2 By Surgical Procedures
6.4.3.4 South Korea Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.4.2 By Surgical Procedures
6.4.3.5 Singapore Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.5.2 By Surgical Procedures
6.4.3.6 Malaysia Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.6.2 By Surgical Procedures
6.4.3.7 Thailand Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.6.2 By Surgical Procedures
6.4.3.8 Indonesia Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.7.2 By Surgical Procedures
6.4.3.9 Vietnam Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.8.2 By Surgical Procedures
6.4.3.10 Taiwan Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.10.1 By Surgical Devices
6.4.3.10.2 By Surgical Procedures
6.4.3.11 Rest of Asia Pacific Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.4.3.11.1 By Surgical Devices
6.4.3.11.2 By Surgical Procedures
6.5 Middle East and Africa Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.3.1 Saudi Arabia Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.3.1.2 By Surgical Procedures
6.5.3.2 U.A.E. Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.3.2.2 By Surgical Procedures
6.5.3.3 Israel Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.3.3.2 By Surgical Procedures
6.5.3.4 South Africa Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5.3.4.2 By Surgical Procedures
6.5.3.5.2 By Surgical Procedures
6.6 Central & South America Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6.3.1 Brazil Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6.3.1.2 By Surgical Procedures
6.6.3.2 Argentina Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6.3.2.2 By Surgical Procedures
6.6.3.3 Chile Lung Cancer Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6.3.3.2 By Surgical Procedures
6.6.3.3.2 By Surgical Procedures
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.4.1.1 Business Description & Financial Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2.1 Business Description & Financial Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Ackermann Instrumente GmbH
7.4.3.1 Business Description & Financial Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4.1 Business Description & Financial Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5.1 Business Description & Financial Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6.1 Business Description & Financial Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 Phoenix Surgical Holdings Limited
7.4.7.1 Business Description & Financial Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8.1 Business Description & Financial Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9.1 Business Description & Financial Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Sontec Instruments Inc.
7.4.10.1 Business Description & Financial Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11.1 Business Description & Financial Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8.1.2 Market Scope & Segmentation
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.4 Discussion Guide for Primary Participants
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
LIST OF TABLES
1 Global Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
2 Surgical Hand Instruments Market, By Region, 2020-2028 (USD Mllion)
3 Monitoring & Visualization Systems Market, By Region, 2020-2028 (USD Mllion)
4 Endoscopic Equipment Market, By Region, 2020-2028 (USD Mllion)
5 Global Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
6 Thoracotomy Market, By Region, 2020-2028 (USD Mllion)
7 Minimally Invasive Devices Market, By Region, 2020-2028 (USD Mllion)
8 Regional Analysis, 2020-2028 (USD Mllion)
9 North America Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
10 North America Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
11 U.S. Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
12 U.S. Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
13 Canada Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
14 Canada Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
15 Mexico Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
16 Mexico Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
17 Europe Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
18 Europe Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
19 Germany Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
20 Germany Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
21 U.K. Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
22 U.K. Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
23 France Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
24 France Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
25 Italy Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
26 Italy Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
27 Spain Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
28 Spain Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
29 Netherlands Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
30 Netherlands Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
31 Rest Of Europe Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
32 Rest Of Europe Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
33 Asia Pacific Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
34 Asia Pacific Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
35 China Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
36 China Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
37 Japan Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
38 Japan Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
39 India Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
40 India Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
41 South Korea Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
42 South Korea Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
43 Singapore Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
44 Singapore Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
45 Thailand Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
46 Thailand Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
47 Malaysia Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
48 Malaysia Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
49 Indonesia Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
50 Indonesia Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
51 Vietnam Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
52 Vietnam Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
53 Taiwan Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
54 Taiwan Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
55 Rest of APAC Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
56 Rest of APAC Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
57 Middle East AND Africa Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
58 Middle East AND Africa Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
59 Saudi Arabia Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
60 Saudi Arabia Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
61 UAE Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
62 UAE Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
63 Israel Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
64 Israel Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
65 South Africa Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
66 South Africa Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
67 Rest Of Middle East AND Africa Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
68 Rest Of Middle East AND Africa Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
69 Central & South America Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
70 Central & South America Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
71 Brazil Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
72 Brazil Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
73 Chile Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
74 Chile Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
75 Argentina Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
76 Argentina Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
77 Rest Of Central & South America Lung Cancer Market, By Surgical Devices, 2020-2028 (USD Mllion)
78 Rest Of Central & South America Lung Cancer Market, By Surgical Procedures, 2020-2028 (USD Mllion)
79 Olympus Corporation: Products & Services Offering
80 Teleflex Incorporated: Products & Services Offering
81 Ackermann Instrumente GmbH: Products & Services Offering
82 Medtronic Plc.: Products & Services Offering
83 Siemens Healthcare: Products & Services Offering
84 RICHARD WOLF GMBH: Products & Services Offering
85 Phoenix Surgical Holdings Limited : Products & Services Offering
86 FusionKraft: Products & Services Offering
87 KLS Martin Group: Products & Services Offering
88 Sontec Instruments Inc.: Products & Services Offering
89 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Lung Cancer Market Overview
2 Global Lung Cancer Market Value From 2020-2028 (USD Mllion)
3 Global Lung Cancer Market Share, By Surgical Devices (2022)
4 Global Lung Cancer Market Share, By Surgical Procedures (2022)
5 Global Lung Cancer Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Lung Cancer Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Lung Cancer Market
10 Impact Of Challenges On The Global Lung Cancer Market
11 Porter’s Five Forces Analysis
12 Global Lung Cancer Market: By Surgical Devices Scope Key Takeaways
13 Global Lung Cancer Market, By Surgical Devices Segment: Revenue Growth Analysis
14 Surgical Hand Instruments Market, By Region, 2020-2028 (USD Mllion)
15 Monitoring & Visualization Systems Market, By Region, 2020-2028 (USD Mllion)
16 Endoscopic Equipment Market, By Region, 2020-2028 (USD Mllion)
17 Global Lung Cancer Market: By Surgical Procedures Scope Key Takeaways
18 Global Lung Cancer Market, By Surgical Procedures Segment: Revenue Growth Analysis
19 Thoracotomy Market, By Region, 2020-2028 (USD Mllion)
20 Minimally Invasive Devices Market, By Region, 2020-2028 (USD Mllion)
21 Regional Segment: Revenue Growth Analysis
22 Global Lung Cancer Market: Regional Analysis
23 North America Lung Cancer Market Overview
24 North America Lung Cancer Market, By Surgical Devices
25 North America Lung Cancer Market, By Surgical Procedures
26 North America Lung Cancer Market, By Country
27 U.S. Lung Cancer Market, By Surgical Devices
28 U.S. Lung Cancer Market, By Surgical Procedures
29 Canada Lung Cancer Market, By Surgical Devices
30 Canada Lung Cancer Market, By Surgical Procedures
31 Mexico Lung Cancer Market, By Surgical Devices
32 Mexico Lung Cancer Market, By Surgical Procedures
33 Four Quadrant Positioning Matrix
34 Company Market Share Analysis
35 Olympus Corporation: Company Snapshot
36 Olympus Corporation: SWOT Analysis
37 Olympus Corporation: Geographic Presence
38 Teleflex Incorporated: Company Snapshot
39 Teleflex Incorporated: SWOT Analysis
40 Teleflex Incorporated: Geographic Presence
41 Ackermann Instrumente GmbH: Company Snapshot
42 Ackermann Instrumente GmbH: SWOT Analysis
43 Ackermann Instrumente GmbH: Geographic Presence
44 Medtronic Plc.: Company Snapshot
45 Medtronic Plc.: Swot Analysis
46 Medtronic Plc.: Geographic Presence
47 Siemens Healthcare: Company Snapshot
48 Siemens Healthcare: SWOT Analysis
49 Siemens Healthcare: Geographic Presence
50 RICHARD WOLF GMBH: Company Snapshot
51 RICHARD WOLF GMBH: SWOT Analysis
52 RICHARD WOLF GMBH: Geographic Presence
53 Phoenix Surgical Holdings Limited : Company Snapshot
54 Phoenix Surgical Holdings Limited : SWOT Analysis
55 Phoenix Surgical Holdings Limited : Geographic Presence
56 FusionKraft: Company Snapshot
57 FusionKraft: SWOT Analysis
58 FusionKraft: Geographic Presence
59 KLS Martin Group.: Company Snapshot
60 KLS Martin Group.: SWOT Analysis
61 KLS Martin Group.: Geographic Presence
62 Sontec Instruments Inc.: Company Snapshot
63 Sontec Instruments Inc.: SWOT Analysis
64 Sontec Instruments Inc.: Geographic Presence
65 Other Companies: Company Snapshot
66 Other Companies: SWOT Analysis
67 Other Companies: Geographic Presence
The Global Lung Cancer Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Lung Cancer Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS